Mechanisms and Novel Treatment Options for Non-Small-Cell Lung Cancer
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 67
Special Issue Editor
Interests: metabolism; non-small-cell lung cancer; immunotherapy; KRAS; LKB1
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lung cancer is the most common cause of tumour-related deaths worldwide, accounting for 18.4% of all cancer deaths. NSCLC is most common, representing roughly 85% of all lung cancer cases in the US and Europe, and has the highest mortality rate. Significant improvements in the clinical outcome for lung cancer patients have been achieved over the past decade, and this is a result of the introduction of targeted therapies in genetically selected subpopulations of patients, as well as the unprecedented efficacy of immunotherapy. Despite this, only a small proportion of patients respond to immunotherapy and few patients achieve long-term survival.
This Special Issue will encompass research that focuses on novel mechanisms and treatment options for NSCLC, with the objective of bringing together the most novel research in the field. This will provide a comprehensive view of NSCLC, offering a valuable tool for basic and translational scientists. We seek high-quality original research and review papers on topics that include, but are not limited to, the following: mechanisms of NSCLC development and progression, cell death in NSCLC, the interplay between NSCLC cells and the tumour microenvironment, novel therapeutic options targeting NSCLC, biomarkers of response to therapeutics targeting NSCLC, strategies to overcome resistance to treatment for NSCLC, and advances in technology and models to study NSCLC.
Dr. Catríona M. Dowling
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- NSCLC
- tumor microenvironment
- novel therapeutic
- biomarkers
- resistance
- advances in technology
- in vitro and ex vivo models
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
